Company
Headquarters: Beijing, China
Employees: 3,005
CN¥21.92 Billion
CNY as of Jan. 1, 2026
US$3.12 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥51.95 B |
| EBITDA | CN¥2.68 B |
| Gross Profit TTM | CN¥3.42 B |
| Profit Margin | 3.87% |
| Operating Margin | 3.81% |
| Quarterly Revenue Growth | 3.60% |
China National Medicines Corp Ltd has the following listings and related stock indices.
Stock: SSE: 600511 wb_incandescent